Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
Authors
Keywords
-
Journal
BMC CANCER
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-14
DOI
10.1186/s12885-022-09848-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner
- (2022) Shouji Zhang et al. Molecular Therapy-Nucleic Acids
- EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
- (2021) Shunsuke Okamura et al. BMC CANCER
- Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
- (2021) Sushil Kumar et al. Nature Communications
- Overexpression of microRNA‑486 affects the proliferation and chemosensitivity of mesothelioma cell lines by targeting PIM1
- (2021) Silvana Pinelli et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner
- (2021) Peng Wang et al. Frontiers in Cell and Developmental Biology
- He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway
- (2021) Jun Kan et al. PHYTOMEDICINE
- Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3
- (2020) Yujin Li et al. BIOTECHNOLOGY LETTERS
- Propofol Affects Non–Small-Cell Lung Cancer Cell Biology By Regulating the miR-21/PTEN/AKT Pathway In Vitro and In Vivo
- (2020) Xiaoyu Zheng et al. ANESTHESIA AND ANALGESIA
- The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4
- (2020) Zhiwei Xing et al. OncoTargets and Therapy
- Anesthetic propofol epigenetically regulates breast cancer trastuzumab resistance through IL-6/miR-149-5p axis
- (2020) Dan Tian et al. Scientific Reports
- Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
- (2020) Anqi Wang et al. Cancer Medicine
- Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer
- (2020) Wenjing Wang et al. Molecular Cancer
- Monotropein alleviates H2O2‑induced inflammation, oxidative stress and apoptosis via NF‑κB/AP‑1 signaling
- (2020) Feng Jiang et al. Molecular Medicine Reports
- Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1
- (2020) Hongbo Wu et al. Cell Death & Disease
- The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?
- (2020) Chin-King Looi et al. Biomedicines
- miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2
- (2020) Hailian Du et al. Molecular Medicine Reports
- NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity
- (2019) Keywan Mortezaee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
- (2019) Alberto Cruz-Bermúdez et al. FREE RADICAL BIOLOGY AND MEDICINE
- Propofol inhibits pancreatic cancer progress under hypoxia via ADAM 8
- (2019) Yutong Gao et al. Journal of Hepato-Biliary-Pancreatic Sciences
- MicroRNA-486-5p improves nonsmall-cell lung cancer chemotherapy sensitivity and inhibits epithelial–mesenchymal transition by targeting twinfilin actin binding protein 1
- (2019) Xiaoyan Jin et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9
- (2019) Chuangzhou Rao et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting NF-κB-Mediated Inflammatory Pathways in Cisplatin-Resistant NSCLC
- (2019) Sarah-Louise Ryan et al. LUNG CANCER
- Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7
- (2019) Xufeng Pan et al. Cell Death & Disease
- MiR-486-5p Serves as a Good Biomarker in Nonsmall Cell Lung Cancer and Suppresses Cell Growth With the Involvement of a Target PIK3R1
- (2019) Fei Tian et al. Frontiers in Genetics
- Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition
- (2019) Shenghu Guo et al. Aging-US
- Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway
- (2019) Mao-mao Zhu et al. BIOMEDICINE & PHARMACOTHERAPY
- Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
- (2019) Dan Wang et al. Journal for ImmunoTherapy of Cancer
- LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis
- (2019) Dong Fu et al. Aging-US
- Pterostilbene Attenuates Astrocytic Inflammation and Neuronal Oxidative Injury After Ischemia-Reperfusion by Inhibiting NF-κB Phosphorylation
- (2019) Haixiao Liu et al. Frontiers in Immunology
- MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A
- (2019) Jinchang Lu et al. EXPERIMENTAL CELL RESEARCH
- Propofol inhibits lung cancer A549 cells growth and epithelial-mesenchymal transition process by up-regulation of microRNA-1284
- (2018) Wei-Zhen Liu et al. ONCOLOGY RESEARCH
- miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer
- (2018) Zhao-jia Gao et al. PATHOLOGY RESEARCH AND PRACTICE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer
- (2017) Nengli Yang et al. ONCOLOGY REPORTS
- Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
- (2017) Lu Xiao et al. Cell Death & Disease
- Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
- (2017) Meng Zhang et al. Cancer Biology & Medicine
- Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
- (2016) Antonio Rossi et al. Expert Review of Anticancer Therapy
- Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer
- (2016) Fei Tian et al. GENE
- PRL-3 activates NF-κB signaling pathway by interacting with RAP1
- (2012) Shenyi Lian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
- (2010) Hsiangling Teo et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started